BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12921523)

  • 1. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 4. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
    Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
    Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction.
    Cuneo BF; Benson DW
    Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734
    [No Abstract]   [Full Text] [Related]  

  • 6. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy.
    Edwards A; Peek MJ; Curren J
    Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):110-2. PubMed ID: 10099764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia.
    Krapp M; Baschat AA; Gembruch U; Geipel A; Germer U
    Ultrasound Obstet Gynecol; 2002 Feb; 19(2):158-64. PubMed ID: 11876808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia.
    Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM
    Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis.
    Barjot P; Hamel P; Calmelet P; Maragnes P; Herlicoviez M
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):353-8. PubMed ID: 9539287
    [No Abstract]   [Full Text] [Related]  

  • 11. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment, observation and outcome of fetal supraventricular tachycardia in a twin pregnancy.
    Schiermeier S; van Leeuwen P; Reinhard J; Gronemeyer D; Hatzmann W
    Fetal Diagn Ther; 2008; 24(4):327-30. PubMed ID: 18836269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
    Ebenroth ES; Cordes TM; Darragh RK
    Pediatr Cardiol; 2001; 22(6):483-7. PubMed ID: 11894150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of supraventricular tachycardia with flecainide acetate: a case report.
    Amano K; Harada Y; Shoda T; Nishijima M; Hiraishi S
    Fetal Diagn Ther; 1997; 12(6):328-31. PubMed ID: 9475360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolysis alters plasma flecainide levels in newborn infants.
    Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
    Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal supraventricular tachyarrhythmias refractory to initial therapy].
    Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D
    Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.